289 related articles for article (PubMed ID: 19208913)
1. Interleukin-21 is required for the development of type 1 diabetes in NOD mice.
Sutherland AP; Van Belle T; Wurster AL; Suto A; Michaud M; Zhang D; Grusby MJ; von Herrath M
Diabetes; 2009 May; 58(5):1144-55. PubMed ID: 19208913
[TBL] [Abstract][Full Text] [Related]
2. IL-21 regulates SOCS1 expression in autoreactive CD8
Sutherland APR; Graham KL; Papadimitriou M; Jhala G; Trivedi P; Catterall T; Fynch S; Kay TWH; Thomas HE
Sci Rep; 2019 Oct; 9(1):15302. PubMed ID: 31653894
[TBL] [Abstract][Full Text] [Related]
3. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
4. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.
Balasa B; Van Gunst K; Jung N; Balakrishna D; Santamaria P; Hanafusa T; Itoh N; Sarvetnick N
J Immunol; 2000 Sep; 165(5):2841-9. PubMed ID: 10946317
[TBL] [Abstract][Full Text] [Related]
5. IL-1 receptor deficiency slows progression to diabetes in the NOD mouse.
Thomas HE; Irawaty W; Darwiche R; Brodnicki TC; Santamaria P; Allison J; Kay TW
Diabetes; 2004 Jan; 53(1):113-21. PubMed ID: 14693705
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells.
Chen MC; Proost P; Gysemans C; Mathieu C; Eizirik DL
Diabetologia; 2001 Mar; 44(3):325-32. PubMed ID: 11317664
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ induced by IL-12 administration prevents diabetes by inhibiting pathogenic IL-17 production in NOD mice.
Zhang J; Huang Z; Sun R; Tian Z; Wei H
J Autoimmun; 2012 Feb; 38(1):20-8. PubMed ID: 22186068
[TBL] [Abstract][Full Text] [Related]
8. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
9. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas.
Rothe H; Ito Y; Kolb H
J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.
Chong MM; Chen Y; Darwiche R; Dudek NL; Irawaty W; Santamaria P; Allison J; Kay TW; Thomas HE
J Immunol; 2004 May; 172(9):5714-21. PubMed ID: 15100317
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.
Cameron MJ; Arreaza GA; Grattan M; Meagher C; Sharif S; Burdick MD; Strieter RM; Cook DN; Delovitch TL
J Immunol; 2000 Jul; 165(2):1102-10. PubMed ID: 10878389
[TBL] [Abstract][Full Text] [Related]
12. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O
J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
[TBL] [Abstract][Full Text] [Related]
14. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
[TBL] [Abstract][Full Text] [Related]
15. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.
Cardozo AK; Proost P; Gysemans C; Chen MC; Mathieu C; Eizirik DL
Diabetologia; 2003 Feb; 46(2):255-66. PubMed ID: 12627325
[TBL] [Abstract][Full Text] [Related]
17. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.
Rabinovitch A
Diabetes Metab Rev; 1998 Jun; 14(2):129-51. PubMed ID: 9679667
[TBL] [Abstract][Full Text] [Related]
18. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.
Hancock WW; Polanski M; Zhang J; Blogg N; Weiner HL
Am J Pathol; 1995 Nov; 147(5):1193-9. PubMed ID: 7485382
[TBL] [Abstract][Full Text] [Related]
19. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
20. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
